Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-022-30613-z
Download full text from publisher
References listed on IDEAS
- Md Mahmudul Hasan & Sumi Sukumaran Nair & Jacqueline G. O’Leary & LuAnn Thompson-Snipes & Verah Nyarige & Junwen Wang & Walter Park & Mark Stegall & Raymond Heilman & Goran B. Klintmalm & HyeMee Joo &, 2021. "Implication of TIGIT+ human memory B cells in immune regulation," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
- Shabnam Shalapour & Joan Font-Burgada & Giuseppe Di Caro & Zhenyu Zhong & Elsa Sanchez-Lopez & Debanjan Dhar & Gerald Willimsky & Massimo Ammirante & Amy Strasner & Donna E. Hansel & Christina Jamieso, 2015. "Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy," Nature, Nature, vol. 521(7550), pages 94-98, May.
- Ping Shen & Toralf Roch & Vicky Lampropoulou & Richard A. O’Connor & Ulrik Stervbo & Ellen Hilgenberg & Stefanie Ries & Van Duc Dang & Yarúa Jaimes & Capucine Daridon & Rui Li & Luc Jouneau & Pierre B, 2014. "IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases," Nature, Nature, vol. 507(7492), pages 366-370, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Channakeshava Sokke Umeshappa & Patricia Solé & Jun Yamanouchi & Saswat Mohapatra & Bas G. J. Surewaard & Josep Garnica & Santiswarup Singha & Debajyoti Mondal & Elena Cortés-Vicente & Charlotte D’Mel, 2022. "Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
- Akshay J. Patel & Zena N. Willsmore & Naeem Khan & Alex Richter & Babu Naidu & Mark T. Drayson & Sophie Papa & Andrew Cope & Sophia N. Karagiannis & Esperanza Perucha & Gary W. Middleton, 2022. "Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30613-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.